As of Thursday close, Bone Biologics Corporation’s (NASDAQ:BBLG) stock was up $0.18, moving up 22.12 percent to $0.98. The average number of shares traded per day over the past five days has been 2,141,700 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.3700 fall in that time frame. In the last twenty days, the average volume was 651,540, while in the previous 50 days, it was 447,874.
Since last month, BBLG stock retreated -25.76%. Shares of the company fell to $0.7510 on 08/15/23, the lowest level in the past month. A 52-week high of $54.00 was reached on 02/16/23 after having rallying from a 52-week low of $0.75. Since the beginning of this year, BBLG’s stock price has dropped by -84.42% or -$5.3110, and marked a new high 11 times. However, the stock has declined by -98.19% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Financial Health
In the three months ended June 29, Bone Biologics Corporation’s quick ratio stood at 1.70, while its current ratio was 1.70, showing that the company is able to pay off its debt.
BBLG’s revenue rose 100.0% to $2.91 million during the quarter, while net income inched up to -$0.56 million. While analysts expected Bone Biologics Corporation to report -$1.5 quarterly earnings, the actual figure was -$0.48 per share, beating the consensus estimate by 68.00%. The liabilities of Bone Biologics Corporation were 1.93 million at the end of its most recent quarter ended June 29. The value of shareholders’ equity is $3.13 million.
Technical Picture
This quick technical analysis looks at Bone Biologics Corporation’s (BBLG) price momentum. With a historical volatility rate of 248.38%, the RSI 9-day stood at 33.93% on 17 August.
With respect to its five-day moving average, the current Bone Biologics Corporation price is down by -27.41% percent or -$0.3700. At present, BBLG shares trade -25.48% below its 20-day simple moving average and -86.38% percent below its 100-day simple moving average. However, the stock is currently trading approximately -83.49% below its SMA50 and -93.26% below its SMA200.
Stochastic coefficient K was 15.85% and Stochastic coefficient D was 15.19%, while ATR was 0.1952. Given the Stochastic reading of 31.85% for the 14-day period, the RSI (14) reading has been calculated as 32.67%. As of today, the MACD Oscillator reading stands at -0.3200, while the 14-day reading stands at -0.3733.
Analyst Ratings
Bone Biologics Corporation (BBLG) has been rated Buy by analysts. According to 0 brokerage firms, BBLG is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Bone Biologics Corporation stock as buy, with 1 recommending it as overweight.
With a median target price of $4.88, the current consensus forecast for the stock is $2.25 – $7.50. Based on these forecasts, analysts predict Bone Biologics Corporation (BBLG) will achieve an average price target of $4.88.
